These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7526363)

  • 21. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study].
    Bian XM; Liu JT; Qi QW; Jiang YL; Li Y; Liu SY; Hao N; Zhou J; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Liao C; Cai Y; Wang H; Wang Z; Zhu J; Hu YL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
    Macri JN; Spencer K; Garver K; Buchanan PD; Say B; Carpenter NJ; Muller F; Boué A
    Prenat Diagn; 1994 Feb; 14(2):97-103. PubMed ID: 7514291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
    Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
    Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of total and free beta-HCG assays in Down syndrome screening.
    Stone S; Henley R; Reynolds T; John R
    Prenat Diagn; 1993 Jun; 13(6):535-7. PubMed ID: 7690482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of parity on human chorionic gonadotrophin levels and Down's syndrome screening.
    Haddow JE; Palomaki GE; Knight GJ
    J Med Screen; 1995; 2(1):28-30. PubMed ID: 7497141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters.
    Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
    Br J Obstet Gynaecol; 1997 Jul; 104(7):811-7. PubMed ID: 9236646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary multiple marker screening for Down's syndrome.
    Cuckle HS; Iles RK; Sehmi IK; Chard T; Oakey RE; Davies S; Ind T
    Prenat Diagn; 1995 Aug; 15(8):745-51. PubMed ID: 7479593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of gravidity on maternal serum markers for Down's syndrome.
    Barkai G; Goldman B; Ries L; Chaki R; Cuckle H
    Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
    Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL
    Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
    Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
    Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second trimester screening for Down's syndrome: 7 years experience.
    Beaman JM; Goldie DJ
    J Med Screen; 2001; 8(3):128-31. PubMed ID: 11678551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
    Piggott M; Wilkinson P; Bennett J
    J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syndrome.
    Spencer K
    Clin Chem; 1991 Jun; 37(6):809-14. PubMed ID: 1710952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.